Cargando…
Plasma Membrane Pores Drive Inflammatory Cell Death
Necroptosis and pyroptosis are two forms of regulated cell death. They are executed by the proteins mixed-lineage kinase domain-like (MLKL) and gasdermin D (GSDMD), respectively. Once activated by numerous pathways, these proteins form membrane pores that allow the influx and efflux of various ions,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471660/ https://www.ncbi.nlm.nih.gov/pubmed/32974349 http://dx.doi.org/10.3389/fcell.2020.00817 |
_version_ | 1783578815767773184 |
---|---|
author | Kolbrink, Benedikt Riebeling, Theresa Kunzendorf, Ulrich Krautwald, Stefan |
author_facet | Kolbrink, Benedikt Riebeling, Theresa Kunzendorf, Ulrich Krautwald, Stefan |
author_sort | Kolbrink, Benedikt |
collection | PubMed |
description | Necroptosis and pyroptosis are two forms of regulated cell death. They are executed by the proteins mixed-lineage kinase domain-like (MLKL) and gasdermin D (GSDMD), respectively. Once activated by numerous pathways, these proteins form membrane pores that allow the influx and efflux of various ions, proteins, and water, ultimately resulting in the death of the cell. These modalities of cell death are considered highly inflammatory because of the release of inflammatory cytokines and damage-associated molecular patterns, and are thereby not only deleterious for the dying cell itself, but also its environment or the entire organism. The relevance for these processes has been observed in various physiological and pathophysiological conditions, ranging from viral and bacterial infections over autoimmune and chronic inflammatory diseases to ischemic organ damage. In recent years, initial in vitro experiments have shed light on a range of connections between necroptosis and pyroptosis. Initial in vivo studies also indicate that, in many disease models, these two forms of cell death cannot be considered individually, as they demonstrate a complex interaction. In this article, we provide an overview of the currently known structure, pathways of activation, and functions of MLKL and GSDMD. With emerging evidence for an interconnection between necroptosis and pyroptosis in not only in vitro, but also in vivo models of disease, we highlight in particular the clinical relevance of the crosslinks between these two forms of inflammatory cell death and their implications for novel therapeutic strategies in a variety of diseases. |
format | Online Article Text |
id | pubmed-7471660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74716602020-09-23 Plasma Membrane Pores Drive Inflammatory Cell Death Kolbrink, Benedikt Riebeling, Theresa Kunzendorf, Ulrich Krautwald, Stefan Front Cell Dev Biol Cell and Developmental Biology Necroptosis and pyroptosis are two forms of regulated cell death. They are executed by the proteins mixed-lineage kinase domain-like (MLKL) and gasdermin D (GSDMD), respectively. Once activated by numerous pathways, these proteins form membrane pores that allow the influx and efflux of various ions, proteins, and water, ultimately resulting in the death of the cell. These modalities of cell death are considered highly inflammatory because of the release of inflammatory cytokines and damage-associated molecular patterns, and are thereby not only deleterious for the dying cell itself, but also its environment or the entire organism. The relevance for these processes has been observed in various physiological and pathophysiological conditions, ranging from viral and bacterial infections over autoimmune and chronic inflammatory diseases to ischemic organ damage. In recent years, initial in vitro experiments have shed light on a range of connections between necroptosis and pyroptosis. Initial in vivo studies also indicate that, in many disease models, these two forms of cell death cannot be considered individually, as they demonstrate a complex interaction. In this article, we provide an overview of the currently known structure, pathways of activation, and functions of MLKL and GSDMD. With emerging evidence for an interconnection between necroptosis and pyroptosis in not only in vitro, but also in vivo models of disease, we highlight in particular the clinical relevance of the crosslinks between these two forms of inflammatory cell death and their implications for novel therapeutic strategies in a variety of diseases. Frontiers Media S.A. 2020-08-21 /pmc/articles/PMC7471660/ /pubmed/32974349 http://dx.doi.org/10.3389/fcell.2020.00817 Text en Copyright © 2020 Kolbrink, Riebeling, Kunzendorf and Krautwald. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Kolbrink, Benedikt Riebeling, Theresa Kunzendorf, Ulrich Krautwald, Stefan Plasma Membrane Pores Drive Inflammatory Cell Death |
title | Plasma Membrane Pores Drive Inflammatory Cell Death |
title_full | Plasma Membrane Pores Drive Inflammatory Cell Death |
title_fullStr | Plasma Membrane Pores Drive Inflammatory Cell Death |
title_full_unstemmed | Plasma Membrane Pores Drive Inflammatory Cell Death |
title_short | Plasma Membrane Pores Drive Inflammatory Cell Death |
title_sort | plasma membrane pores drive inflammatory cell death |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471660/ https://www.ncbi.nlm.nih.gov/pubmed/32974349 http://dx.doi.org/10.3389/fcell.2020.00817 |
work_keys_str_mv | AT kolbrinkbenedikt plasmamembraneporesdriveinflammatorycelldeath AT riebelingtheresa plasmamembraneporesdriveinflammatorycelldeath AT kunzendorfulrich plasmamembraneporesdriveinflammatorycelldeath AT krautwaldstefan plasmamembraneporesdriveinflammatorycelldeath |